Penumbra, Inc.

PEN: NYSE
49Total

Lowest reading is at 25 out of 100. All scores are out of 100.

About The Company

CEO

Mr. Adam Elsesser J.D.

Market Cap

12.56 Billion USD

Sector

Healthcare

Website

https://www.penumbrainc.com

Last Update

27/09/2026, 17:26:14

Description

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally.

Read More

Strongest readings

  • ✔Altman-Z score of 18.14 sits above the distress range
  • ✔Financial health is strong (health score 85 out of 100)
  • ✔Debt is low at 0.14 times equity

Weakest readings

  • ✘Price-to-earnings of 78.7 is above the market average of 19.6
  • ✘The current price sits above estimated fair value (margin of safety -87.81%)
  • ✘Share count has been rising at 0.40% per year

Key Figures

StatusMetricValueReadingMarket avg
✘
Price / earnings (TTM)
78.74x
19.60x
✘
Margin of safety (DCF)
-87.81%
17.95%
✘
Revenue growth (5y average)
4.49%
10.97%
✘
Dividend yield (TTM)
0.00%
1.85%
✘
Share count, per year
0.40%
0.00%
✘Return on capital employed2.67%
10.00%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

Valuation

25 / 100

Priced above the market on most measures.

StatusMetricValueReadingMarket avg
✘
Price / earnings
78.74x
19.60x
✘Free cashflow yield1.41%
4.70%
✘Price / earnings growth13.07x
1.50x
Price / book8.21x
—
✘
Margin of safety
-87.81%
17.95%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

  • ✘Estimated intrinsic value of 38.86 USD is below the current price of 318.89 USD

Desired Margin Of Safety

0%

▼

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Estimated Fair Value: 49.4 USD ✘

Current Price: 318.9 USD

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated fair value for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel for the impact this has on longterm investment returns and find a margin of safety you are comfortable with.

Growth

43 / 100

Growing more slowly than the market on most measures.

StatusMetricValueReadingMarket avg
✘
Revenue growth
4.49%
10.97%
✘Earnings growth3.01%
14.48%
✔Cashflow growth18.55%
12.35%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

  • ✔Revenue growth has improved this year (21.25% against a five year average of 4.49%)
  • ✔Earnings growth has improved this year (694.12% against a five year average of 3.01%)
  • ✔Free cashflow growth has improved this year

Health

85 / 100

Balance sheet covers its obligations.

Measured on Leverage and capital, Funding and liquidity, Earnings quality.

StatusMetricValueReadingThreshold
✔Altman-Z score18.14
3.00
✔Piotroski score7.00
5.00
✔Debt / equity0.14x
0.80x
✔Current ratio5.75x
1.00x
✔Interest coverage149.51x
2.50x
✔Free cashflow / debt0.15x
0.15x
✔Debt / capital0.12x
1.00x

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    Management

    43 / 100

    Returns on capital are below the market.

    StatusMetricValueReadingMarket avg
    ✘Return on equity2.27%
    15.00%
    ✘Return on capital employed2.67%
    10.00%
    Return on assets1.76%
    —
    Free cashflow return on capital1.87%
    —
    ✘Return on capital, 5y change-0.02%
    0.00%
    ✘
    Share count, per year
    0.40%
    0.00%
    ✘Share count, recent0.09%
    0.00%
    Realized buyback returnN/A0.00%
    ✔Goodwill erosion / equity0.06%
    2.00%
    Price volatility, 5 year40.10%
    —

    The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    • ✔New shares were issued while the value score was 25 out of 100

    Analysts

    not enough data
    StatusMetricValueReadingNeutral
    Analyst opinion scoreN/A50

    The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    Financial History

    Annual figures across the full reporting history we hold.

    Market Peers

    PEN

    SEC Filings

    Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

    See 35+ Years Annual Reports

    Other Information

    Company Name

    Penumbra, Inc.

    Currency

    USD

    Beta

    0.698

    Vol Avg

    349793

    Ceo

    Mr. Adam Elsesser J.D.

    Cik

    0001321732

    Cusip

    Exchange

    NYSE

    Full Time Employees

    4700

    Industry

    Medical Devices

    Sector

    Healthcare

    Ipo Date

    Address

    One Penumbra Place

    City

    Alameda

    State

    CA

    Country

    United States

    Zip

    94502

    Phone

    510 748 3200

    Analysis Last Updated

    27/09/2026, 17:26:14

    Financial data compiled from SEC EDGAR filings and Yahoo Finance.

    Noticed an error with something on our site?

    Data, not advice. Do your own diligence.

    We Use Cookies